Effects of Placenta Location in Pregnancy Outcomes of Placenta Accreta Spectrum (PAS): A Retrospective Cohort Study
,
Abstract
Objective: Placenta Accreta Spectrum (PAS) affects approximately one in a thousand deliveries. Very few studies evaluated PAS risk factors based on their location. In this study, we have investigated the effects of placenta location on placental adhesion-related complications, its risk factors, and outcomes.
Materials and methods: We performed a retrospective cohort study of pathology-confirmed cases of PAS from patients with peripartum hysterectomy, at a large educational hospital in Qazvin, Iran, from 2009 to 2019. Placenta location was found by ultrasound reports and intraoperative evaluation. We measured demographic features, basic characteristics, maternal and neonatal outcomes based on placental location including anterior, posterior, and lateral in Placenta Accreta Spectrum. Chi-square, t-test, and one-way ANOVA were used to examine the relation of complications, risk factors, and outcomes in PAS.
Results: A review of 70 cases showed the distribution of placenta location as follows: 57% anterior, 27% posterior, and 16% lateral. The mean gestational age at delivery was 35 (33-39) weeks. In 78.6% (n=55) of the patients, an association with placenta previa and in 94/2% (n=66) of cases a history of cesarean section was found, however, it was not significantly correlated with placenta location (p=0.082). We found that surgery duration was significantly longer in patients with lateral PAS (155±38, vs 129.35±33.8 and 133.15±31.5 for anterior and posterior placenta respectively, p=0.09). Patients with lateral PAS also bled more than the remaining two groups (2836 ml for lateral PAS vs 2002 and 1847 for anterior and posterior placenta respectively, p=0.022). Moreover, women with a history of uterine surgery were more likely to have posterior PAS compared to those with anterior and lateral PAS (p=0.035).
Conclusion: Differences in complications, risk factors, and outcomes of PAS based on placenta location may lead to improved diagnosis and decreased morbidity in women.
J Obstet Gynecol 2017; 217: 27-36.
2. Turan OM, Shannon A, Asoglu MR, Goetzinger KR. A novel approach to reduce blood loss in patients with placenta accreta spectrum disorder. J Matern Fetal Neonatal Med 2021; 34: 2061-70.
3. Hussein AM, Momtaz M, Elsheikhah A, Abdelbar A, Kamel A. The role of ultrasound in prediction of
intra-operative blood loss in cases of placenta accreta spectrum disorders. Arch Gynecol Obstet 2020; 302: 1143-50.
4. Kiliçci Ç, Eken Mk, Ilhan G, Çöğendez E, Şanverdi I, Keskin M, et al. Evaluation of Risk Factors, Incidence, Perinatal and Maternal Outcome of Placenta Previa Cases with and without Placenta Accreta Spectrum.
Duzce Medical Journal 2017; 19: 75-80.
5. Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet Gynecol Int. 2012; 2012: 873929.
6. Faranesh R, Romano S, Shalev E, Salim R. Suggested approach for management of placenta percreta invading the urinary bladder. Obstet Gynecol 2007; 110 : 512-5.
7. Sekiguchi A, Nakai A, Kawabata I, Hayashi M, Takeshita T. Type and location of placenta previa affect preterm delivery risk related to antepartum hemorrhage. Int J Med Sci 2013; 10:1683-8.
8. Jang DG, We JS, Shin JU, Choi YJ, Ko HS, Park IY, et al. Maternal outcomes according to placental position in placental previa. Int J Med Sci 2011; 8: 439-44 .
9. Liu J, Xie XQ. Influence of different attachment sites of placenta previa on maternal and child outcomes of re-pregnancy after cesarean section. China Modern Medicine 2014.
10. Morgan EA, Sidebottom A, Vacquier M, Wunderlich W, Loichinger M. The effect of placental location in cases of placenta accreta spectrum. Am J Obstet Gynecol 2019; 221: 357.e1-357.e5.
11. Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am
J Obstet Gynecol 2019; 221: 208-18.
12. van Beekhuizen HJ, Stefanovic V, Schwickert A, Henrich W, Fox KA, MHallem Gziri M, et al. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum. Acta Obstet Gynecol Scand 2021; 100 Suppl 1: 12-20.
13. Schwickert A, van Beekhuizen HJ, Bertholdt C, Fox KA, Kayem G, Morel O, et al. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): a multinational database study. Acta Obstet Gynecol Scand 2021; 100 Suppl 1: 29-40.
14. Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212: 218-e1-9.
15. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009; 116: 648-54.
16. Wright JD, Pri-Paz S, Herzog TJ, Shah M, Bonanno C, Lewin SN, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol 2011; 205: 38-e1-6.
17. Contro E, Maroni E, Cera E, Youssef A, Bellussi F, Pilu G, et al. Unilaterally increased uterine artery resistance, placental location and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 2010; 153: 143-7.
18. Takahashi H, Baba Y, Usui R, Suzuki H, Ohkuchi A, Matsubara S. Laterally-positioned placenta in placenta previa. J Matern Fetal Neonatal Med 2020; 33: 2642-8.
19. Baba Y, Matsubara S, Ohkuchi A, Usui R, Kuwata T, Suzuki H, et al. Anterior placentation as a risk factor for massive hemorrhage during cesarean section in patients with placenta previa. J Obstet Gynaecol Res 2014; 40: 1243-8.
20. Matsubara S, Kuwata T, Usui R, Watanabe T, Izumi A, Ohkuchi A, et al. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand 2013; 92: 372-7.
21. Baldwin HJ, Patterson JA, Nippita TA, Torvaldsen S, Ibiebele I, Simpson JM, et al. Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet Gynecol 2018; 131: 227-33.
22. Tinari S, Buca D, Cali G, Timor‐Tritsch I, Palacios‐Jaraquemada J, Rizzo G, et al. Systematic review and meta‐analysis of posterior placenta accreta spectrum disorders: risk factors, histopathology and diagnostic accuracy. Ultrasound Obstet Gynecol 2021; 57: 903-9.
23. Tourette C, Bretelle F, Cravello L, D'Ercole C, Boubli L, Gamerre M, et al. Comparative study of patients with placenta accreta with or without a history of cesarean section. J Gynecol Obstet Biol Reprod (Paris) 2014; 43: 322-7.
24. Zeng C, Yang M, Ding Y, Duan S, Zhou Y. Placenta accreta spectrum disorder trends in the context of the universal two‐child policy in China and the risk of hysterectomy. Int J Gynaecol Obstet 2018; 140: 312-8.
25. Zeevi G, Tirosh D, Baron J, Sade MY, Segal A, Hershkovitz R. The risk of placenta accreta following primary cesarean delivery. Arch Gynecol Obstet 2018; 297: 1151-6.
26. Kassem GA, Alzahrani AK. Maternal and neonatal outcomes of placenta previa and placenta accreta: three years of experience with a two-consultant approach. Int J Womens Health 2013; 5: 803-10.
27. Jauniaux E, Grønbeck L, Bunce C, Langhoff-Roos J, Collins SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ open 2019; 9: e031193.
28. Gielchinsky Y, Mankuta D, Rojansky N, Laufer N, Gielchinsky I, Ezra Y. Perinatal outcome of pregnancies complicated by placenta accreta. Obstet Gynecol 2004; 104: 527-30.
29. Crane JM, Van den Hof MC, Dodds L, Armson BA, Liston R. Neonatal outcomes with placenta previa. Obstet Gynecol 1999; 93: 541-4.
30. McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol 1985; 65: 176-82.
31. Zakherah MS, Abdel-Aziz M, Othman ER, Abbas AM. Maternal and neonatal outcomes of placenta previa and accreta at Assiut women’s health hospital, Egypt. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2018; 7: 3024-8.
32. Morlando M, Schwickert A, Stefanovic V, Gziri MM, Pateisky P, Chalubinski KM, et al. Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study. Acta Obstet Gynecol Scand 2021; 100 Suppl 1:41-9.
| Files | ||
| Issue | Vol 15, No 4 (December 2021) | |
| Section | Original Articles | |
| DOI | https://doi.org/10.18502/jfrh.v15i4.7888 | |
| Keywords | ||
| Hysterectomy Maternal Mortality Placenta Accreta Postpartum Hemorrhage Placenta Previa | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
